Breaking News
WWIII EXCLUSIVE: A Cease-Fire Between Ukraine & Russia Is Secretly Being Negotiated...
The Fight For Bitcoin Jesus! Roger Ver Faces 109 Years In Prison #FreeRoger (upcoming broadcast)
Trump nominates Pam Bondi for US attorney general
"What if I told you Senator Matt Gaetz was the plan all along...
Top Tech News
Spinning fusion fuel for efficiency and Burn Tritium Ten Times More Efficiently
Rocket plane makes first civil supersonic flight since Concorde
Muscle-powered mechanism desalinates up to 8 liters of seawater per hour
Student-built rocket breaks space altitude record as it hits hypersonic speeds
Researchers discover revolutionary material that could shatter limits of traditional solar panels
In case you missed it, Ben Affleck just dropped the best talk on AI and where we're heading:
LG flexes its display muscle with stretchable micro-LED screen
LiFePO4 Charging Guidelines: What is 100%? What is 0%?! How to Balance??
Skynet On Wheels: Chinese Tech Firm Reveals Terrifying Robo-Dog
Energy company claims its new fusion technology can provide heat and power to 70,000 homes:
'TUMOUR KILLER' Cancer patients 'CURED' after doctors turbocharge their blood's
Two adults with leukaemia have been in remission since 2010 after Car-T therapy.
It involves removing blood and genetically modifying its white cells so they target cancer.
The resulting Car-T cells are re-injected in a type of immunotherapy which uses the body's immune system to attack tumours.
Levels of the cells in the two cured patients remain high.
Dr Carl June, of the University of Pennsylvania, US, said: "Based on these results, we can conclude that Car-T cells can cure leukaemia.
"These cells continued to demonstrate tumour-killing characteristics."
Patient Doug Olsen said medics could not find any cancer after a few weeks. He said: "I knew the doctors weren't sure but I was pretty convinced that I was done with cancer."
The NHS offers Car-T to some children with leukaemia and adults with lymphoma.
It warns the therapy can make the immune system over-react or trigger side effects such as fever, vomiting or breathing difficulties.